Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1253
| Despition | Pin1 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1130 | Native Bovine GFAP Protein (AC1130) | 25 µl | inquiry |
| ACPP-1712 | Human NME2 Protein (AC1712) | 5 µg | inquiry |
| ACPP-1369 | Parkin Blocking Peptide (AC1369) | 250 µg | inquiry |
| ACPP-1296 | Human FGF 19 Protein (AC1296) | 5 µg | inquiry |
| ACPP-1349 | Estrogen Receptor alpha Blocking Peptide (AC1349) | 250 µg | inquiry |
| ACPP-1317 | Noelin Blocking Peptide (AC1317) | 250 µg | inquiry |
| ACPP-1822 | Human CHGA Protein, GST (AC1822) | 2 µg | inquiry |
| ACPP-1352 | Myocilin Blocking Peptide (AC1352) | 250 µg | inquiry |
| ACPP-1522 | Dopamine Receptor D3 Blocking Peptide (AC1522) | 250 µg | inquiry |
| ACPP-1188 | GRIK1 Blocking Peptide (AC1188) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.